Smart money doesn’t wait for the headlines, it follows the charts. These three smallcap stocks are forming strong breakout patterns…
Precision oncology is reshaping cancer care in India, driven by cheaper sequencing, AI‑powered mutation discovery, and pharma investment, creating a…
Track key corporate actions this week with major dividend payouts and Bajaj Auto’s Rs 5,600-cr buyback—check eligibility now!
Autos, telecom and IT lift Q4 earnings, but cracks in banking and consumer sectors keep growth uneven JM Financial reveals…
Nuvama bets big on 5 stocks with up to 60% upside driven by capacity expansion, strong order books and earnings…
Monday watchlist, March 30: Track Sun Pharma, HDFC Bank and ICICI as market volatility surges; review key stock setups and…
UBS warns India’s midcap valuations remain high despite 2025 correction, as fund flows keep SMIDs resilient and fund managers shift…
Strong growth in medical testing has benefited leading pathological laboratory chains. And two leading chains have recently declared bonus issues.…
India’s ₹26B diagnostic boom is reshaping healthcare. Discover how Dr Lal PathLabs and Thyrocare Technologies are revolutionising India’s medical future.
While pharmaceutical sector faces pressure because of US tariff uncertainty, Laboratory stocks are gradually recovering and gaining strength. These stocks…
Nuvama recommends buying HUL, Dr Lal Pathlabs, and IndiaMart for up to 52% potential upside; explore their analysis for investment…
Q4 Results: Today, companies like Maruti Suzuki India, Tata Technologies, RBL Bank, Hindustan Zinc, Bank of Maharashtra, Dr Lal PathLabs,…
Goel was instrumental in bringing the Company’s IPO in 2015 and led many small and mid-size M&A including a large…
Dr Lal PathLabs posted revenue from operations at Rs 601.30 crore, up 12.6 per cent as against Rs 533.80 crore…
Dr Lal PathLabs posted revenue from operations at Rs 541 crore, up 7.6 per cent in comparison to Rs 502.70…
Dr Lal PathLabs on Thursday said its consolidated profit after tax declined 8 per cent to Rs 57 crore for…
Dr Lal PathLabs was started in 1949 by the late SK Lal – He was a Junior Doctor in the…
Nifty Pharma index rises 2% as pharma, diagnostics stocks rally amid renewed Covid-19 outbreak fears. Dr Lal PathLabs, Vijaya Diagnostic…